Categories
Latest Industry Intelligence
Lu Rahman looks at the role precision medicine is playing in how we approach the [...]
RSV is a complicated virus, and traditional vaccine methods have not worked. But UW’s Institute [...]
Gamma Biosciences has agreed to make a controlling investment in Mirus Bio for nucleic acid delivery based in Madison, Wisconsin. The transaction will support Mirus’ plans to expand good manufacturing practice (GMP) production and commercialisation of its flagship product TransIT VirusGEN for large scale manufacturing of AAV and LV-based viral vectors for gene therapy, as […]
Menu
≡
╳
